Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4671-4679

  Hampe, Christiane S ^a   Hammerle, Lisa P ^a   Bekris, Lynn ^a   Örtqvist, Eva ^b   Kockum, Ingrid ^b   Rolandsson, Olov ^c   Landin Olsson, Mona ^d   Torn, Carina ^d   Persson, Bengt ^b   Lernmark, Åke ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE; HYBRID PROTEIN;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EPITOPES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; ISOENZYMES; MALE; PHENOTYPE; RADIOIMMUNOASSAY; RECOMBINANT PROTEINS;

EID: 17744387308     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.12.4671     Document Type: Article

References (38)

1. Two genes encode distinct glutamate decarboxylase
2. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10
3. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene
4. Glutamic acid decarboxylase: An autoantigen in insulin-dependent diabetes mellitus
5. Differential expression of glutamic acid decarboxylase in rat and human islets
6. Differential localization of two glutamic acid decarboxylases (GAD65 and GAD67) in adult monkey visual cortex
7. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase
8. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes
9. Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target difference epitopes
10. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase
11. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes
12. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
13. GAD autoantibodies in IDDM, Stiff-Man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes
14. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: At diagnosis and following treatment
15. Progression to type 1 diabetes in autoimmune endocrine patients with islet cell antibodies
16. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I
17. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
18. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64K autoantibody positivity at onset predicts diabetes type
19. Glutamate decarboxylaseinsulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children
20. Prevalence of islet cell (ICA) and insulin (IAA) autoantibodies in normal French children (Abstract)
21. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus
22. Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult onset diabetes
23. Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index
24. Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: Follow-up of the Seattle Family Study
25. Species-specific autoantibodies in type 1 diabetes
26. A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes
27. GAD65- and IA-2 autoantibodies in adults are associated with abnormal glucose tolerance but not necessarily with later appearance of type 1 diabetes
28. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent mellitus
29. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
30. 3H recombinant human ligands
31. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs
32. A novel micro-assay for insulin autoantibodies
33. Towards a WHO approved standard sample for ICA, GAD65 and IA-2 autoantibodies
34. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood IDDM
35. Maturation of the humoral autoimmune response to epitopes of GAD in prechnical childhood type 1 diabetes
36. Autoantigenic properties of native and denatured glutamic acid decarboxylase: Evidence for a conformational epitope
37. A rat brain cDNA encodes enzymatically active GABA transaminase and provides a molecular probe for GABA-catabohzing cells
38. Cloning and sequence analysis of a murine cDNA encoding glutamate decarboxylase (GAD65)